GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (FRA:1TZ) » Definitions » Price-to-Operating-Cash-Flow

InfuSystems Holdings (FRA:1TZ) Price-to-Operating-Cash-Flow : 12.48 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is InfuSystems Holdings Price-to-Operating-Cash-Flow?

As of today (2024-05-26), InfuSystems Holdings's share price is €6.25. InfuSystems Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.50. Hence, InfuSystems Holdings's Price-to-Operating-Cash-Flow Ratio for today is 12.48.

The historical rank and industry rank for InfuSystems Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:1TZ' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.57   Med: 9.95   Max: 24.41
Current: 13.19

During the past 13 years, InfuSystems Holdings's highest Price-to-Operating-Cash-Flow Ratio was 24.41. The lowest was 4.57. And the median was 9.95.

FRA:1TZ's Price-to-Operating-Cash-Flow is ranked better than
70.16% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 20.84 vs FRA:1TZ: 13.19

InfuSystems Holdings's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.50.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of InfuSystems Holdings was -10.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year.

During the past 13 years, InfuSystems Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.20% per year. The lowest was -20.90% per year. And the median was 4.25% per year.


InfuSystems Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for InfuSystems Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Price-to-Operating-Cash-Flow Chart

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.81 20.11 20.49 10.68 20.35

InfuSystems Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.81 21.12 19.63 20.35 15.81

Competitive Comparison of InfuSystems Holdings's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Price-to-Operating-Cash-Flow falls into.



InfuSystems Holdings Price-to-Operating-Cash-Flow Calculation

InfuSystems Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=6.25/0.501
=12.48

InfuSystems Holdings's Share Price of today is €6.25.
InfuSystems Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

InfuSystems Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (FRA:1TZ) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

InfuSystems Holdings (FRA:1TZ) Headlines

No Headlines